{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:52:03Z","timestamp":1782471123029,"version":"3.54.5"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaleida Troup Funding","award":["030GRT00000091"],"award-info":[{"award-number":["030GRT00000091"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background: Cancer treatment-induced ulcerative mucositis (UM) is a debilitating toxicity in patients with cancers of the lip, oral cavity, and pharynx (CLOP). This study evaluated the association of chemotherapy-induced (CT-UM) and radiotherapy-induced ulcerative mucositis (RT-UM) with burden of illness (BOI), focusing on hospital length of stay (LOS) and total charges, and examined disparities in outcomes. Methods: This retrospective cohort study analyzed 2019 National Inpatient Sample (NIS) data. Adult patients (\u226518 years) hospitalized with CLOP (ICD-10-CM C00\u2013C14) undergoing inpatient surgery, chemotherapy, or radiotherapy were included. CT-UM (K12.31) and RT-UM (K12.33) were identified as secondary diagnoses. Survey-weighted generalized linear models (negative binomial for LOS; gamma for charges) adjusted for demographics, comorbidities (Elixhauser score), insurance, income, and Diagnosis-Related Groups (DRG; surgical vs. medical) were used. Results: Among 59,710 weighted CLOP hospitalizations, 820 had CT-UM and 1010 had RT-UM. Patients with UM were younger and had varying comorbidity burdens. Unadjusted analyses showed prolonged geometric mean LOS for CT-UM (5.66 vs. 3.81 days, p &lt; 0.001) and RT-UM (4.95 vs. 3.81 days, p = 0.001), with lower total charges ($48,645 and $42,938 vs. $56,267). Multivariable analyses confirmed RT-UM was associated with increased LOS (adjusted coefficient 1.33, 95% CI 1.14\u20131.55) but lower charges (0.67, 95% CI 0.56\u20130.81). In patients &gt;50 years, CT-UM showed stronger effects (LOS 1.80, 95% CI 1.49\u20132.15; charges 0.79, 95% CI 0.65\u20130.98). Significant disparities were observed: females, Black and Hispanic patients, and Medicaid beneficiaries experienced greater BOI (prolonged LOS and\/or higher charges in subgroups). Associations persisted in DRG- and procedure-stratified sensitivity analyses, suggesting treatment interruptions as a key driver. Conclusions: Ulcerative mucositis in hospitalized CLOP patients is associated with prolonged LOS but lower charges, likely due to treatment modifications, and disproportionately affects vulnerable populations. These findings highlight the need for proactive oral care protocols, multidisciplinary integration, and equity-focused interventions to reduce the burden of this toxicity and improve cancer treatment outcomes.<\/jats:p>","DOI":"10.3390\/reports9030203","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:43:57Z","timestamp":1782463437000},"page":"203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospitalized Patients with Oral Cavity Cancer and Ulcerative Mucositis: Implications for Key Cost Drivers and Disparities"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2505-3014","authenticated-orcid":false,"given":"Lauryn","family":"Rudin","sequence":"first","affiliation":[{"name":"Department of Medicine, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[{"name":"City of Hope Comprehensive Cancer Center, Duarte CA and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical System, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karrar","family":"Aljanahi","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diggory","family":"Cordova","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Rajesh","sequence":"additional","affiliation":[{"name":"College of Dental Medicine, Nova Southeastern University, Davie, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Meleveedu","sequence":"additional","affiliation":[{"name":"UConn Health: Neag Comprehensive Cancer Center, University of Connecticut, 135 Dowling Way 4th Floor, Farmington, CT 06030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-6627","authenticated-orcid":false,"given":"Poolakkad S.","family":"Satheeshkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University at Buffalo, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","first-page":"lgz011","article-title":"Oral Mucositis Due to High-Dose Chemotherapy and\/or Head and Neck Radiation Therapy","volume":"2019","author":"Lalla","year":"2019","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cden.2013.12.005","article-title":"Chemotherapy or radiation-induced oral mucositis","volume":"58","author":"Lalla","year":"2014","journal-title":"Dent. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/cam4.1221","article-title":"Common oral complications of head and neck cancer radiation therapy: Mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis","volume":"6","author":"Sroussi","year":"2017","journal-title":"Cancer Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cncr.21622","article-title":"Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma","volume":"106","author":"Oster","year":"2006","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.23898","article-title":"Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life","volume":"113","author":"Elting","year":"2008","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist"},{"key":"ref_8","first-page":"23","article-title":"Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes","volume":"5","author":"Rosenthal","year":"2007","journal-title":"J. Support. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/hed.26879","article-title":"The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers","volume":"43","author":"Rybkin","year":"2021","journal-title":"Head Neck"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamaoto.2018.2716","article-title":"Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review","volume":"145","author":"Graboyes","year":"2019","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1038\/s41598-022-08491-8","article-title":"Hospitalization rates from radiotherapy complications in the United States","volume":"12","author":"Tonse","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jpainsymman.2008.12.004","article-title":"Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy","volume":"38","author":"Murphy","year":"2009","journal-title":"J. Pain. Symptom Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40273-013-0081-2","article-title":"The economic burden of toxicities associated with cancer treatment: Review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue","volume":"31","author":"Carlotto","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"ref_16","first-page":"3969","article-title":"Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"27","author":"Zadik","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_17","first-page":"3949","article-title":"Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"27","author":"Hong","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_18","first-page":"2449","article-title":"Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"28","author":"Correa","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdsr.2020.02.001","article-title":"Oral management strategies for radiotherapy of head and neck cancer","volume":"56","author":"Kawashita","year":"2020","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_20","unstructured":"Healthcare Cost and Utilization Project (HCUP) (2023, June 06). NIS Database Documentation, Available online: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp."},{"key":"ref_21","first-page":"22","article-title":"Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients","volume":"33","author":"Mohan","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00784-021-04106-0","article-title":"Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients","volume":"26","author":"Satheeshkumar","year":"2022","journal-title":"Clin. Oral Investig."},{"key":"ref_23","first-page":"199","article-title":"Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma","volume":"31","author":"Satheeshkumar","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mohan, M.P., Epstein, J.B., Meleveedu, K.S., Padhi, P., Pili, R., and Satheeshkumar, P.S. (2025). Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients\u2019 Overall Burden of Illness. Pharmaceuticals, 18.","DOI":"10.3390\/ph18040536"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"lgz010","DOI":"10.1093\/jncimonographs\/lgz010","article-title":"Costs of Oral Complications of Cancer Therapies: Estimates and a Blueprint for Future Study","volume":"2019","author":"Elting","year":"2019","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Eichhorn, S., Rudin, L., Ramasamy, C., Varsani, R., Padhi, P., Nassour, N., Meleveedu, K., Epstein, J.B., Semegran, B., and Pili, R. (2025). Elevated likelihood of infectious complications related to oral mucositis after hematopoietic stem cell transplantation: A systematic review and meta-analysis of outcomes and risk factors. Cancers, 17.","DOI":"10.3390\/cancers17162657"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Satheeshkumar, P.S., Gopalakrishnan, V., Epstein, J.B., and Pili, R. (2026). Long-term clinical consequences of severe oral mucositis in survivors of lip, oral cavity, and pharynx cancer versus leukemia: A propensity-score-matched comparative cohort study using real-world data. Med. Sci., 14.","DOI":"10.20944\/preprints202602.1503.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1002\/cncr.30212","article-title":"Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies","volume":"122","author":"Naghavi","year":"2016","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jamaoto.2013.2549","article-title":"Treatment patterns and survival among low-income Medicaid patients with head and neck cancer","volume":"139","author":"Subramanian","year":"2013","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Baliga, S., Yildiz, V.O., Bazan, J., Palmer, J.D., Jhawar, S.R., Konieczkowski, D.J., Grecula, J., Blakaj, D.M., Mitchell, D., and Henson, C. (2023). Disparities in survival outcomes among racial\/ethnic minorities with head and neck squamous cell cancer in the United States. Cancers, 15.","DOI":"10.3390\/cancers15061781"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/01945998221077197","article-title":"A systematic review of head and neck cancer health disparities: A call for innovative research","volume":"166","author":"Nallani","year":"2022","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/1055-9965.EPI-22-0114","article-title":"Oral cancer prevalence, mortality, and costs in Medicaid and commercial insurance claims data","volume":"31","author":"Tranby","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104563","DOI":"10.1016\/j.ijmedinf.2021.104563","article-title":"Feature selection and predicting chemotherapy-induced ulcerative mucositis using machine learning methods","volume":"154","author":"Satheeshkumar","year":"2021","journal-title":"Int. J. Med. Inform."},{"key":"ref_35","first-page":"651","article-title":"Guided supportive care may benefit from predicting cancer treatment-induced toxicity\u2014A methodology paper on utilization of nomograms to predict severe oral mucositis, Part I","volume":"33","author":"Satheeshkumar","year":"2025","journal-title":"Support. Care Cancer"}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:37:33Z","timestamp":1782470253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["reports9030203"],"URL":"https:\/\/doi.org\/10.3390\/reports9030203","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}